Report: POAG patients who smoke experience advanced retinal nerve fiber layer thinning

Article

It was reported that the more individuals smoke, the faster the retinal nerve fiber layer (RNFL) becomes thinner.

A recent report shows that the more individuals smoke, the faster the retinal nerve fiber layer (RNFL) becomes thinner.1

Takashi Nishida, MD, PhD, from the Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, CA, and his associates conducted a longitudinal study of the relationship between smoking and smoking intensity and the rate with which the RNFL becomes thinner in patients with primary open-angle glaucoma (POAG).

The investigators studied patients with POAG who had had a minimum of 3 years of follow-up with a minimum of 5 visits to obtain optical coherence tomography (OCT) images.

The investigators defined the smoking intensity as the pack-years at the time the baseline OCT images were obtained.

The study included 466 eyes of 314 patients. The mean follow-up was 6.6 years (range, 6.4-6.7 years). Any history of smoking was reported by 39% of patients (n = 121).

“Greater smoking intensity was associated with faster RNFL thinning (−0.06; 95% confidence interval, −0.11-0.00) µm/year per 10 pack-years higher,” the researchers reported. This finding reached significance (p=0.031) after adjustment for confounding factors.

The thinning of the RNFL proceeded significantly faster when the smoking intensity exceeded 8 pack-years.

The study concluded thatthe smoking intensity was associated with faster rates of thinning of the RNFL.

Nishida and colleagues suggested that evaluation of the smoking intensity might add information to the assessment of the risk of glaucoma progression. However, they also noted that future studies are required to investigate if smoking cessation as a modifiable risk factor can decrease progression in patients with glaucoma.

Reference
1. Nishida T, Mahmoudinezhad G, Weinreb RN, et al. Smoking and progressive retinal nerve fibre layer thinning in glaucoma. Br J Ophthalmol. 2022; published online September 13, 2022; http://dx.doi.org/10.1136/bjo-2022-321237
Recent Videos
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
Mile Brujic, OD, FAAO; Nate Lighthizer, OD, FAAO; Brianna Rhue, OD, FAAO, FSLS; Ben Casella, OD; and Ben Gaddie, OD, FAAO shared their insights from the conference.
Agatha Sleboda, OD; Arti Shah, OD, FAAO; and Kent J. Nozacki, OD provide the best tips that they give to their patients during natural disasters events in light of the recent Greater Los Angeles wildfires.
Optometrists local to the Los Angeles area overview their efforts to continue providing support to patients affected by January's wildfires.
Brianna Rhue, OD, FAAO, FSLS, reviewed key takeaways from The Future of Myopia Management: Perspectives from Leading Experts talk from SECO 2025.
Dr. Nate Lighthizer shares key takeaways from the SECO Showcase on anterior segment technology and full laser certification course offered at SECO.
Dr. Julie Rodman discusses retina, imaging, and posterior segment in SECO presentations
© 2025 MJH Life Sciences

All rights reserved.